ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Syndrome

Acute Myeloid Leukemia (AML) trials near Cleveland, OH, USA:

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (TUSCANY)

to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...

Enrolling
Relapsed Adult AML
Leukemia, Myeloid, Acute
Drug: Venetoclax Oral Tablet
Drug: Tuspetinib

Phase 1, Phase 2

Aptose Biosciences

Cleveland, Ohio, United States and 33 other locations

allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...

Active, not recruiting
AML
Acute Myelogenous Leukemia
Drug: Iomab-B
Drug: Conventional Care

Phase 3

Actinium Pharmaceuticals
Actinium Pharmaceuticals

Cleveland, Ohio, United States and 23 other locations

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Myeloid Sarcoma
Nucleophosmin 1-mutated Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Cytarabine

Phase 1

Kura Oncology

Cleveland, Ohio, United States and 43 other locations

Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Gilteritinib
Drug: Daunorubicin

Phase 2

PrECOG

Cleveland, Ohio, United States and 43 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Cleveland, Ohio, United States and 180 other locations

). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....

Enrolling
Acute Myeloid Leukemia
Drug: Tagraxofusp
Drug: Azacitidine

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Cleveland, Ohio, United States and 32 other locations

GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...

Active, not recruiting
Leukemia
Drug: GDX012
Drug: Chemotherapy Agents

Phase 1, Phase 2

Takeda
Takeda

Cleveland, Ohio, United States and 13 other locations

with cytarabine in patients with relapsed/refractory (r/r) acute myeloid leukemia (AML) or r/r higher-risk myelod...

Enrolling
AML, Adult
MDS
Drug: Eganelisib
Drug: Eganelisib in combination with cytarabine

Phase 1

Stelexis BioSciences

Cleveland, Ohio, United States and 11 other locations

This is a multi-center, randomized, double-blinded, placebo controlled trial.

Enrolling
Adult Acute Myeloid Leukemia
Drug: mocravimod

Phase 3

Priothera

Cleveland, Ohio, United States and 104 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cleveland, Ohio, United States and 277 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems